YU YONG (VP, Clinical Trial Operations) sold 3.6% of their position (9.68K shares) of GENELUX CORP on the open market
Open‑market sale worth $26.7K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 9/2/2026ACC: 0001493152-26-041283
Officer· VP, Clinical Trial Operations
Since Jan 2023
-9.68K
Net shares
Net seller
$26.7K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
9.68K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−9.68K
Price / share
$2.75
Trade value
$26.66K
% of position
3.6%
8/31/2026
268.37K→258.69K
Total
Net shares
−9.68K
Net value
-$26.66K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 8/31/2026 | S · Sale | −9.68K | $2.75 | $26.66K | 3.6% | 268.37K | 258.69K |
| Total | −9.68K | -$26.66K | ||||||
Derivative Transactions0
No derivative transactions reported